Sign In
Buy BSEM
$4.14
-0.0290 (-0.696%)
At Close: Jun 03, 2026
BioStem Technologies® to Debut American Amnion™ at the 2025 Desert Foot Multi-Disciplinary Limb Salvage and Wound Care Conference
07:01am, Wednesday, 10'th Dec 2025
Expanding its Portfolio with American Amnionto Serve the Wound Care Needs of Our Veterans BioStem Technologies launched two new placental-derived allografts—American Amnion and American Amnion AC—
BioStem Technologies® to Debut American Amnion™ at the 2025 Desert Foot Multi-Disciplinary Limb Salvage and Wound Care Conference
07:00am, Wednesday, 10'th Dec 2025
POMPANO BEACH, Fla., Dec. 10, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company specializing in placental-derived biologics for advanced wound care, today anno
BioStem Technologies Expands Product Access in Medicaid
09:26am, Tuesday, 25'th Nov 2025
Florida Medicaid Adds BioStem's VENDAJEⓇ and VENDAJE ACⓇ to Covered Skin Substitutes List Key Takeaways POMPANO BEACH, Fla., Nov. 25, 2025 – PRISM MediaWire (Press Release Service – Press Rel
BioStem Technologies, Inc. (BSEM) Q3 2025 Earnings Call Transcript
07:51pm, Thursday, 13'th Nov 2025
BioStem Technologies, Inc. (OTCPK:BSEM) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants Philip Taylor - Associate Jason Matuszewski - CEO, President, Secretary & Chairman Bran
BioStem Technologies Reports Third Quarter 2025 Financial Results
04:02pm, Thursday, 13'th Nov 2025
Key Takeaways POMPANO BEACH, FL, November 13, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focu
BioStem Technologies Reports Third Quarter 2025 Financial Results
04:02pm, Thursday, 13'th Nov 2025
POMPANO BEACH, Fla., Nov. 13, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-d
BioStem Technologies Announces Filing of Restated Financial Statements
04:01pm, Thursday, 13'th Nov 2025
Key Takeaways POMPANO BEACH, FL, November 13, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies, Inc.
BioStem Technologies Announces Filing of Restated Financial Statements
04:01pm, Thursday, 13'th Nov 2025
POMPANO BEACH, Fla., Nov. 13, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-d
BioStem Technologies Provides Comments on CMS CY 2026 Final Medicare Reimbursement Rule Changes for Skin Substitutes
04:09pm, Wednesday, 05'th Nov 2025
Key Takeaways POMPANO BEACH, Fla., November 5, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies, Inc.
BioStem Technologies Provides Comments on CMS CY 2026 Final Medicare Reimbursement Rule Changes for Skin Substitutes
04:05pm, Wednesday, 05'th Nov 2025
POMPANO BEACH, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company specializing in placental-derived biologics for advanced wound care, today comm
BioStem Technologies Secures Land Purchase at the Research Park at Florida Atlantic University in Boca Raton for Future Headquarters
07:04am, Wednesday, 05'th Nov 2025
Future Relocation and Expansion to Create Up to 100 New Jobs Over 5 Years City Approves Up to $300,000 in Economic Incentives to Rapidly Growing MedTech Business POMPANO BEACH, Fla., Nov. 5, 2025 –
Key Takeaways Randomized controlled trial results published in the International Journal of Tissue Repair demonstrate BioRetain® allografts significantly improve probability of achieving lasting woun
POMPANO BEACH, Fla., Oct. 31, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (“BioStem” or the “Company”) (OTC: BSEM), a leading MedTech company focused on the development, manufacturing,
BioStem Technologies to Host Third Quarter 2025 Financial Results Conference Call on November 13, 2025
04:18pm, Thursday, 30'th Oct 2025
Conference call and webcast to be held at 4:30 PM ET POMPANO BEACH, Fla., October 30, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – BioStem Technologies, Inc.
BioStem Technologies to Host Third Quarter 2025 Financial Results Conference Call on November 13, 2025
04:05pm, Thursday, 30'th Oct 2025
POMPANO BEACH, Fla., Oct. 30, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-d
